Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Oncotarget|June 15, 2018
Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patientsStewart G Martin, Marie N Lebot, Bhudsaban Sukkarn, et al.
BBA Clinical|December 18, 2015
ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancersTarek M A Abdel-Fatah, Arvind Arora, Paul Moseley, et al.
European Journal of Cancer (Oxford, England : 1990)|May 31, 2014
Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breastJeremy Thomas, Andrew Hanby, Sarah E Pinder, et al.
International Journal of Molecular Epidemiology and Genetics|May 4, 2011
Using In silico LD clumping and meta-analysis of genome-wide datasets as a complementary tool to investigate and validate new candidate biomarkers in Alzheimer's diseaseChristopher Medway, Hui Shi, James Bullock, et al.
Proteomics. Clinical Applications|December 8, 2010
Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approachBalwir Matharoo-Ball, Lucy Ratcliffe, Lee Lancashire, et al.
Breast Cancer Research and Treatment|November 21, 2013
Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapyTarek M A Abdel-Fatah, Nada Albarakati, Lara Bowell, et al.
Plos One|July 19, 2016
Correction: Temporal Expression of Peripheral Blood Leukocyte Biomarkers in a Macaca fascicularis Infection Model of Tuberculosis; Comparison with Human Datasets and Analysis with Parametric/Non-parametric Tools for Improved Diagnostic Biomarker IdentificationSajid Javed, Leanne Marsay, Alice Wareham, et al.
Cancer Research|December 21, 2012
Targeting XRCC1 deficiency in breast cancer for personalized therapyRebeka Sultana, Tarek Abdel-Fatah, Rachel Abbotts, et al.
Plos One|May 27, 2016
Temporal Expression of Peripheral Blood Leukocyte Biomarkers in a Macaca fascicularis Infection Model of Tuberculosis; Comparison with Human Datasets and Analysis with Parametric/Non-parametric Tools for Improved Diagnostic Biomarker IdentificationSajid Javed, Leanne Marsay, Alice Wareham, et al.
Proteomics. Clinical Applications|December 8, 2010
Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer modelBaharak Vafadar-Isfahani, Stephanie Anne-Sophie Laversin, Murrium Ahmad, et al.
Pageof 10